Cullen/Frost Bankers’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-70
Closed -$521 1388
2024
Q3
$521 Hold
70
﹤0.01% 1186
2024
Q2
$568 Hold
70
﹤0.01% 1207
2024
Q1
$524 Hold
70
﹤0.01% 984
2023
Q4
$475 Hold
70
﹤0.01% 999
2023
Q3
$456 Hold
70
﹤0.01% 1127
2023
Q2
$384 Hold
70
﹤0.01% 1101
2023
Q1
$659 Hold
70
﹤0.01% 1157
2022
Q4
$818 Hold
70
﹤0.01% 1057
2022
Q3
$1K Hold
70
﹤0.01% 1088
2022
Q2
$1K Hold
70
﹤0.01% 1031
2022
Q1
$1K Hold
70
﹤0.01% 1099
2021
Q4
$1K Buy
+70
New +$556 ﹤0.01% 1119
2020
Q4
Sell
-70
Closed 1107
2020
Q3
$0 Hold
70
﹤0.01% 1198
2020
Q2
$0 Hold
70
﹤0.01% 1112
2020
Q1
$0 Hold
70
﹤0.01% 953
2019
Q4
$0 Hold
70
﹤0.01% 1062
2019
Q3
$0 Hold
70
﹤0.01% 1045
2019
Q2
$0 Hold
70
﹤0.01% 1058
2019
Q1
$0 Buy
+70
New +$244 ﹤0.01% 942

Other funds holding HHS

Cullen/Frost Bankers's HHS Position: Q4 2024 in Review

Cullen/Frost Bankers sold out of Harte-Hanks (HHS) in Q4 2024, closing a stake of 70 shares — an estimated $521 sold.

Cullen/Frost Bankers first reported a position in HHS in Q1 2019 and held it in 19 quarters. The position peaked at $1K in Q3 2022. 23 funds tracked by Wall St. Rank hold HHS as of Q4 2024.

  • Cullen/Frost Bankers reported no remaining Harte-Hanks position as of Q4 2024 after selling out during the quarter.
  • Cullen/Frost Bankers sold 70 Harte-Hanks shares in Q4 2024, an estimated $521.
  • Cullen/Frost Bankers first reported a position in Harte-Hanks in Q1 2019 and held it in 19 quarters.
  • Cullen/Frost Bankers's Harte-Hanks position peaked at $1K in Q3 2022.
  • 23 funds tracked by Wall St. Rank held Harte-Hanks as of Q4 2024.

Based on Cullen/Frost Bankers's 13F filing for Q4 2024, filed 6 Feb 2025.